Bodyport

Bodyport is a San Francisco-based digital health company commercializing an integrated hardware and software platform for remote heart failure monitoring. Its core product, the Bodyport Cardiac Scale, uses advanced sensors and algorithms to measure hemodynamic biomarkers through a patient's feet, with data transmitted to a clinical care portal. The company's Congestion Index algorithm has demonstrated in clinical studies the ability to detect twice as many heart failure events as standard weight monitoring. Bodyport targets health systems and providers with a solution designed for seamless integration and remote patient management (RPM) reimbursement.

Integrated digital health platform featuring an FDA-cleared connected scale (Cardiac Scale) that non-invasively measures hemodynamic biomarkers through the feet, paired with a proprietary algorithm (Congestion Index) that analyzes these biomarkers to detect early signs of worsening heart failure. Data is delivered via a HIPAA-compliant, SOC 2-certified software care platform.

Bodyport competes in the remote heart failure monitoring space against traditional weight-based monitoring, implantable hemodynamic monitors (e.g., Abbott's CardioMEMS), and other wearable devices. Its key differentiation is the non-invasive, multi-parameter biomarker approach that has shown superior event detection to weight alone in clinical studies.